ASM Microbe 2019

American Society for Microbiology

June 20–24, 2019 | San Francisco, CA | Booth 1527

Discover at ASM Microbe in San Francisco how you can elevate your performance and advance patient care with our interdisciplinary portfolio in your clinical laboratory.

Sign up to receive scientific posters, news and alerts for ASM Microbe delivered right to your email inbox.

 Sign up

Elevate your performance. Advance patient care.


Find out at ASM Microbe How You Can Leverage Interdisciplinary Testing to Advance Patient Care

Join us at booth 1527 to see the latest reliable and cost-effective microbiology and urinalysis systems. Hear from peers and scientific experts how you can elevate your performance and advance patient care by delivering precise, accurate results quickly.

Accelerate care with a menu that matters

  • Discover our industry-leading portfolio of in vitro diagnostic tests for sepsis identification and management across multiple disciplines including microbiology, hematology and urinalysis
  • Learn how the Early Sepsis Indicator addresses this prevalent and costly health condition from the hematology laboratory, potentially alerting physicians to sepsis sooner

Bring the benefit of automation to all

  • See how the modular open platform of the Copan WASP® DT specimen processor adapts to the changing needs of your clinical microbiology laboratory. Find out how you can automate all core aspects of microbiology specimen processing, including plating and streaking, Gram-stain slide preparation and enrichment broth inoculation
  • Diminish subjectivity in urinalysis with the iQ Workcell 3000* and significantly reduce the need for manual microscopic review and sample handling

Deliver greater insights through clinical informatics

  • Explore how LabPro Information Manager software enables faster workflow and delivery of test results from order to LIS transmission
  • Witness the accuracy and efficiency of the DxM trio—the trusted AST detection power of the DxM MicroScan WalkAway system, identifications delivered at the speed of mass spectrometry by the Bruker MALDI Biotyper, made conveniently accessible by LabPro-MBT software
  • Find out how LabPro Connect software takes information access to a higher level by allowing multiple users to access LabPro at their workstations or offices for more effective workflow

Unlock hidden value through performance partnership

Learn how your peers are saving costs, maximizing efficiency and evolving their laboratories for the future with Danaher Business System workflow consultation and achieving gold-standard accuracy in antibiotic susceptibility testing results.

Know sooner, act faster: Explore solutions for sepsis 
Attend the Industry and Science Showcase, “Identify, Diagnose and Manage Sepsis Efficiently with Interdisciplinary Testing,” to discover how you can know sooner and act faster when diagnosing and treating sepsis. See the detailed agenda ›

Gain access to helpful resources

We look forward to sharing insights with you in San Francisco. In the meantime, sign up to receive event updates and scientific posters.

Identify, Diagnose and Manage Sepsis Efficiently with Interdisciplinary Testing

Presented by:
Barbara L. Zimmer, Ph.D.
Principal Scientist, Scientific Affairs
Beckman Coulter, Inc.

Location: Industry & Science Showcase Theater North, Exhibit Hall

Date: Saturday, June 22, 1:00 –1:45 p.m.

Sepsis is a global crisis affecting millions of people and costing healthcare organizations billions of dollars. Additionally, sepsis is often difficult to diagnose, treatment is resource intensive and time is critical for positive patient outcomes. Improved outcomes are shown with identifying and diagnosing early, and monitoring patient response to treatment by serial testing. Beckman Coulter’s comprehensive solutions spanning hematology, microbiology, immunoassay, chemistry and urinalysis can be utilized from the moment the patient enters the emergency department through time spent in intensive care. Our unique offering of Early Sepsis Indicator and lactate can help identify sepsis earlier, antimicrobial treatment can be refined with rapid bacteria identification and antibiotic susceptibility testing and patient response to treatment can be monitored with procalcitonin.

Join Beckman Coulter’s ASM Microbe Showcase, “Identify, Diagnose and Manage Sepsis Efficiently with Interdisciplinary Testing” to discover how you can know sooner and act faster when diagnosing and treating sepsis.

About the Presenter: Barbara L. Zimmer, Ph.D.
Barbara L. Zimmer, Ph.D., is a principal scientist for Beckman Coulter. She is also a lecturer in mycology and infectious diseases in the Department of Dermatology at the University of California, Davis, School of Medicine. Dr. Zimmer is an advisor of the CLSI Subcommittee on Antimicrobial Susceptibility Testing. She was previously on the Board of Scientific Counselors’ Antimicrobial Resistance Working Group for the CDC and is the past industry advisor to the Microbiology Devices Panel of the Food and Drug Administration. She is the author of more than 30 papers and 130 posters, and has presented approximately 100 scientific workshops.

Advance Patient Care with Our Comprehensive Solutions






These products may not be available in your country at this time. Please contact your Beckman Coulter sales representative or distributor for more information.

*iQ Workcell configurations include a Beckman Coulter iQ200 interfaced with an Arkray AUTION Max AX-4030.

Kalorama United States Market for In Vitro Diagnostic Tests, 2017, pg. 878.

MALDI Biotyper is the property of Bruker Daltonik GmbH.
WASP is a registered trademark of Copan Italia SpA.
Danaher and its service marks are owned by Danaher Corporation and used with permission.
ARKRAY, the stylized logo, and the ARKRAY products mentioned herein are trademarks or registered trademarks of ARKRAY in the United States.